11 companies · ₹38,874 cr · 4 with AI deep dives · Q2FY27 report
Hospitals add volume faster than beds fill: new-unit losses and govt-payer delays outweigh the CGHS rate lift
Every company here with a deep dive, topped up by market cap. The rest of the industry is in the appendix.
Most providers reported double-digit IP/OP or test-volume growth. Pricing played a secondary role: ARPOB rose 5-10% at most hospital chains, and Metropolis took no price increase.
The outlook and what resolves next quarter
Where these managements said things are heading, and the dated, checkable events that would change it. Free with an account - 3 full reports a quarter.
Create a free account →Sept 26: 0 of 4 reported so far, so it is not in the trend above.
Breadth: 75% of 4 companies grew revenue year on year (was 100% a quarter earlier) and 0% expanded margin (was 25%).
Syngene International Ltd is 38.1% of this industry by market cap. The top 5 are 98.4% and the top 10 are 100%.
| 35.9x |
| 21.5x |
| 18.4% |
| 17.6% |
| +39.7% |
| Unlock |
| Suven Life Sciences Ltd | ₹7,378 cr | - | -27.3x | -78.8% | -3998.8% | +90.9% | Unlock |
| Vimta Labs Ltd | ₹2,172 cr | 24.0x | 14.6x | 25.2% | 34.8% | +11.8% | Unlock |
| Bilcare Ltd | ₹192 cr | 24.7x | 11.5x | 5.5% | 6.1% | +21.2% | Unlock |
| Novelix Pharmaceuticals Ltd | ₹169 cr | - | 49.2x | 10.0% | 2.6% | +65.1% | Unlock |
| Jeevan Scientific Technology Ltd | ₹167 cr | 40.8x | 17.1x | 5.3% | 16.0% | +107.7% | Unlock |
| TAKE Limited | ₹154 cr | 11.9x | 32.2x | 18.5% | -3.5% | - | Unlock |
| Globalspace Technologies Ltd | ₹78 cr | 22.9x | 17.2x | 4.5% | 8.4% | +66.7% | Unlock |
| Adeshwar Meditex Ltd | ₹23 cr | 17.9x | 10.0x | 5.2% | 4.9% | -30.4% | Unlock |
| Vanta Bioscience Ltd | ₹15 cr | 136.0x | 44.6x | 1.2% | 56.1% | +62.4% | Unlock |